ONCOTHERAPY SCIENCE, INC.

News OncoTherapy Science, Inc.

Equities

4564

JP3202150003

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-26 am EDT			5-day change	1st Jan Change
17 ^JPY	-5.56%		-10.53%	-26.09%

Apr. 22	OncoTherapy Science, Inc. cancelled the transaction announced on April 5, 2024	CI
Apr. 05	OncoTherapy Science, Inc. announced that it expects to receive ¥3.78 million in funding from Long Corridor Asset Management Limited and another investor	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

OncoTherapy Science, Inc. cancelled the transaction announced on April 5, 2024	Apr. 21	CI
OncoTherapy Science, Inc. announced that it expects to receive ¥3.78 million in funding from Long Corridor Asset Management Limited and another investor	Apr. 04	CI
Triple Negative Breast Cancer Pipeline, FDA Approvals, Clinical Trials Assessment, Companies 2023 \| Shanghai Henlius Biotech, Jiangsu HengRui Medicine Co., Ltd., G1 Therapeutics, Inc., and others.	Dec. 05	AQ
OncoTherapy Science, Inc.(TSE:4564) dropped from S&P Global BMI Index	23-09-18	CI
OncoTherapy Science, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-12	CI
OncoTherapy Science, Inc. announced that it has received ¥95.95 million in funding	23-04-09	CI
OncoTherapy Science, Inc. announced that it expects to receive ¥95.95 million in funding	23-03-23	CI
OncoTherapy Science : Announcement of the Presentation of Interim Results for Phase I Clinical Study of a Combination of OTSGC-A24 and Immune Checkpoint Inhibitor in Patients with Gastric Cancer	22-09-12	PU
OncoTherapy Science, Inc. announced that it has received ¥12.25 million in funding from Daiwa Securities Co., Ltd., Investment Arm	21-04-27	CI
OncoTherapy Science, Inc. announced that it expects to receive ¥12.25 million in funding from Daiwa Securities Co., Ltd., Investment Arm	21-04-11	CI
OncoTherapy Science : Japanese bio-venture starts development of COVID-19 peptide vaccine	20-10-01	AQ
OncoTherapy Science, Inc. announced that it has received ¥12.013 million in funding from Daiwa Securities Group Inc.	19-01-14	CI
OncoTherapy Science, Inc. announced that it expects to receive ¥12.013 million in funding from Daiwa Securities Group Inc.	18-12-25	CI
Oncotherapy Science, Inc. and Theragen Etex Co.,Ltd., to Form Joint Venture Company	17-07-13	CI
OncoTherapy Science, Inc.(TSE:4564) added to Russell Global Index	15-06-29	CI
Split: 500 of 1	13-09-25	FA
OncoTherapy Science, Inc. Signs Licensing Agreement with Societe d'Exploitation de Produits pour les Industries Chimiques S.A	13-07-30	CI
Shionogi & Co. Signs Agreement with OncoTherapy Science Inc. for Cancer Peptide Vaccines	12-04-01	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
4564 Stock
News OncoTherapy Science, Inc.

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer